| Literature DB >> 25995584 |
Thapanee Roengrit1, Panakaporn Wannanon2, Piyapong Prasertsri3, Yupaporn Kanpetta4, Bung-Orn Sripanidkulchai5, Jintanaporn Wattanathorn2, Naruemon Leelayuwat6.
Abstract
[Purpose] We aimed to evaluate the effects of Phyllanthus amarus (PA) on oxidative stress and damage, inflammation, and soreness in muscle after a single session of moderate-intensity exercise.Entities:
Keywords: Exercise; Muscle damage; Vitamin C
Year: 2015 PMID: 25995584 PMCID: PMC4434005 DOI: 10.1589/jpts.27.1181
Source DB: PubMed Journal: J Phys Ther Sci ISSN: 0915-5287
Anthropometric and physiologic characteristics of participants
| Mean ± SD | |
|---|---|
| Age (yrs) | 22.0±2.90 |
| Height (m) | 1.70±0.06 |
| Body weight (kg) | 63.6±10.7 |
| BMI (kg/m2) | 22.8±3.3 |
| BF (%) | 19.5±9.0 |
| FM (kg) | 12.5±7.3 |
| FFM (kg) | 48.4±6.6 |
| Waist circumference (cm) | 76.7±7.5 |
| Hip circumference (cm) | 94.8±6.1 |
| Waist:hip ratio | 0.81±0.04 |
| VO2, peak (mL/kg body weight/min) | 36.9±5.2 |
| Work loadmax (w) | 136.1±32.4 |
| % VO2, peak during exercise in CTL treatment | 70.8±10.9 |
| % VO2, peak during exercise in PA treatment | 68.4±18.9 |
Values are the mean ± SD; n=12 for each group. BMI: body mass index; % BF: percentage of body fat; FM: fat mass; FFM: fat free mass; VO2, peak: peak oxygen consumption; CTL: placebo control; PA: P. amarus
Daily dietary composition and energy expenditure of participants
| CTL | PA | |
|---|---|---|
| Protein (g) | 122.9±30.6 | 125.4±35.6 |
| Fat (g) | 89.3±30.2 | 78.0±17.4 |
| Carbohydrate (g) | 254.3±71.7 | 239.2±62.9 |
| Fiber (g) | 5.6±2.0 | 7.1±2.1 |
| Thiamine (mg) | 1.3±0.4 | 1.2±0.5 |
| Riboflavin (mg) | 1.9±1.0 | 1.4±0.5 |
| Niacin (mg) | 20.7±6.6 | 18.6±6.5 |
| Vitamin C (mg) | 23.2±18.4 | 27.1±12.2 |
| Vitamin A (RE) | 746.1±1388.8 | 710.4±1382.4 |
| Energy intake (kcal/day) | 2289.2±475.8 | 2112.0±423.2 |
| Energy expenditure (kcal/day) | 2292.1±388.1 | 2127.9±654.6 |
Values are the mean ± SD; n=12 for each group. CTL: placebo control; PA: P. amarus; vitamin A 1 RE = 12 µg beta carotene
Baseline blood parameters of participants
| Mean ± SD | |
|---|---|
| Blood glucose (mM) | 4.6±0.3 |
| Creatinine (µmol/L) | 0.01±0.001 |
| ALT (U/L) | 23.1±24.9 |
| TG (mM) | 1.1±0.3 |
| TC (mM) | 2.6±1.4 |
| LDL (mM) | 2.8±0.9 |
| HDL (mM) | 1.6±0.4 |
Values are the mean ± SD; n=12. ALT: alanine transferase; TG: triglycerides; TC: total cholesterol; LDL: low-density lipoprotein; HDL: high-density lipoprotein
Levels of MDA, vitamin C, NO˙, CK, and hs-CRP before exercise (pre-exercise), as well as immediately after moderate-intensity exercise (post-exercise) and 24 h (post-24 h) and 48 h (post-48 h) after moderate-intensity exercise
| Time | |||||
|---|---|---|---|---|---|
| Pre-exercise | Post-exercise | Post-24 h | Post-48 h | ||
| MDA (nM) | CTL | 1.74±0.45 | 3.09±0.82 | 3.48±0.79 | 2.87±0.95 |
| PA | 1.72±0.40 | 2.59±0.64 | 2.23±0.74 | 2.08±0.63 | |
| Vitamin C (µg/mL) | CTL | 7.97±1.21 | 7.18±1.05 | 7.45±1.20 | 7.35±1.06* |
| PA | 7.82±1.37 | 10.98±1.82# | 11.91±1.96# | 10.92±1.93*,# | |
| NO˙ (nM) | CTL | 141.0±58.4 | 134.8±62.0 | 131.5±27.3 | 113.8±48.4 |
| PA | 145.4±52.1 | 165.3±70.0 | 134.6±16.8 | 144.3±64.2 | |
| CK (U/L) | CTL | 146.2±24.3 | 158.6±25.8* | 167.2±28 | 142.3±21.4 |
| PA | 149.3±24.4 | 157.9±24.3* | 151.7±23.7 | 161.34±32.8 | |
| hs-CRP (mg/L) | CTL | 0.60±0.19 | 0.65±0.2 | 0.74±0.25 | 0.66±0.28 |
| PA | 0.53±0.17 | 0.52±0.17 | 0.71±0.28 | 0.81±0.25 | |
Values are the mean ± SE; n=12 for each group. CTL: placebo control; PA: P. amarus; MDA: malondialdehyde; NO˙: nitric oxide radical. * Significantly different from pre-exercise (p<0.05), # Significantly different from the CTL group at the same time point (p<0.05)
Counts of neutrophils, lymphocytes, and monocytes before exercise (pre-exercise), as well as immediately after moderate-intensity exercise (post-exercise) and 24 h (post-24 h) and 48 h (post-48 h) after moderate-intensity exercise
| Time | |||||
|---|---|---|---|---|---|
| Pre-exercise | Post-exercise | Post-24 h | Post-48 h | ||
| Neutrophils (103/μL) | CTL | 3.65±0.31 | 4.11±0.36* | 3.56±0.30 | 3.41±0.46 |
| PA | 3.23±0.47 | 3.46±0.43 | 3.40±0.22 | 3.58±0.41 | |
| Lymphocytes (103/μL) | CTL | 2.06±0.18 | 2.58±0.34 | 2.05±0.18 | 2.16±0.17 |
| PA | 2.08±0.21 | 2.33±0.22 | 1.95±0.18 | 2.11±0.21 | |
| Monocyte (103/μL) | CTL | 0.46±0.04 | 0.57±0.07 | 0.47±0.06 | 0.42±0.06 |
| PA | 0.52±0.07 | 0.59±0.08 | 0.45±0.07 | 0.52±0.08 | |
Values are the mean ± SE; n=12 for each group. CTL: placebo control; PA: P. amarus. *Significantly different from pre-exercise (p<0.05)
Levels of muscle soreness in the right leg and left leg before exercise (pre-exercise), as well as immediately after moderate-intensity exercise (post-exercise) and 24 h (post 24 h) and 48 h (post 48 h) after moderate-intensity exercise
| Time | |||||
|---|---|---|---|---|---|
| Pre-exercise | Post-exercise | Post-24 h | Post-48 h | ||
| Right leg | CTL | 4.7±0.4 | 4.8±0.4 | 5.0±0.6 | 5.3±0.6 |
| PA | 4.4±0.2 | 4.5±0.5 | 4.9±0.6 | 4.8±0.5 | |
| Left leg | CTL | 4.7±0.4 | 4.6±0.4 | 5.0±0.5 | 5.4±0.5 |
| PA | 4.6±0.4 | 4.4±0.4 | 4.9±0.5 | 5.1±0.5 | |
Values are the mean ± SE; n=12 for each group. CTL: placebo control; PA: P. amarus